Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
De novo pyrimidine biosynthesis enzymes are responsible for the synthesis of pyrimidine nucleotides from basic precursors, essential for DNA/RNA synthesis and cell proliferation. The pathway involves key enzymes like CAD complex (CPSII, ATCase, Dihydroorotase), Dihydroorotate dehydrogenase (DHODH), and Uridine monophosphate synthase (UMPS). These enzymes are drug targets for cancer therapy and antimicrobial agents.
Inhibition of pyrimidine biosynthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on De novo Pyrimidine Biosynthesis Enzymes (N/A).